|
| 36594517 | Data sharing to advance gene-targeted therapies in rare diseases. | Am J Med Genet C Semin Med Genet | 2023 |
| 37031408 | Contributions from medical geneticists in clinical trials of genetic therapies: A points to consider statement of the American College of Medical Genetics and Genomics (ACMG). | Genet Med | 2023 |
| 37279760 | Actionability of unanticipated monogenic disease risks in newborn genomic screening: Findings from the BabySeq Project. | Am J Hum Genet | 2023 |
| 37438524 | A framework for individualized splice-switching oligonucleotide therapy. | Nature | 2023 |
| 36691939 | Are we prepared to deliver gene-targeted therapies for rare diseases? | Am J Med Genet C Semin Med Genet | 2023 |
| 36738469 | Moving away from one disease at a time: Screening, trial design, and regulatory implications of novel platform technologies. | Am J Med Genet C Semin Med Genet | 2023 |
| 36453229 | Whole-genome sequencing holds the key to the success of gene-targeted therapies. | Am J Med Genet C Semin Med Genet | 2023 |
| 36594517 | Data sharing to advance gene-targeted therapies in rare diseases. | Am J Med Genet C Semin Med Genet | 2023 |
| 37279760 | Actionability of unanticipated monogenic disease risks in newborn genomic screening: Findings from the BabySeq Project. | Am J Hum Genet | 2023 |
| 37438524 | A framework for individualized splice-switching oligonucleotide therapy. | Nature | 2023 |
| 37031408 | Contributions from medical geneticists in clinical trials of genetic therapies: A points to consider statement of the American College of Medical Genetics and Genomics (ACMG). | Genet Med | 2023 |
| 36691939 | Are we prepared to deliver gene-targeted therapies for rare diseases? | Am J Med Genet C Semin Med Genet | 2023 |
| 36738469 | Moving away from one disease at a time: Screening, trial design, and regulatory implications of novel platform technologies. | Am J Med Genet C Semin Med Genet | 2023 |
| 36453229 | Whole-genome sequencing holds the key to the success of gene-targeted therapies. | Am J Med Genet C Semin Med Genet | 2023 |
| 35145310 | A solid start for gene therapy in Tay-Sachs disease. | Nat Med | 2022 |
| 36064943 | Integrating rapid exome sequencing into NICU clinical care after a pilot research study. | NPJ Genom Med | 2022 |
| 35860385 | Developing antisense oligonucleotides for a <i>TECPR2</i> mutation-induced, ultra-rare neurological disorder using patient-derived cellular models. | Mol Ther Nucleic Acids | 2022 |
| 35145310 | A solid start for gene therapy in Tay-Sachs disease. | Nat Med | 2022 |
| 35222234 | Modified Sensory Testing in Non-verbal Patients Receiving Novel Intrathecal Therapies for Neurological Disorders. | Front Neurol | 2022 |
| 35860385 | Developing antisense oligonucleotides for a <i>TECPR2</i> mutation-induced, ultra-rare neurological disorder using patient-derived cellular models. | Mol Ther Nucleic Acids | 2022 |
| 36064943 | Integrating rapid exome sequencing into NICU clinical care after a pilot research study. | NPJ Genom Med | 2022 |
| 35222234 | Modified Sensory Testing in Non-verbal Patients Receiving Novel Intrathecal Therapies for Neurological Disorders. | Front Neurol | 2022 |
| 34211152 | Exome and genome sequencing for pediatric patients with congenital anomalies or intellectual disability: an evidence-based clinical guideline of the American College of Medical Genetics and Genomics (ACMG). | Genet Med | 2021 |
| 34211152 | Exome and genome sequencing for pediatric patients with congenital anomalies or intellectual disability: an evidence-based clinical guideline of the American College of Medical Genetics and Genomics (ACMG). | Genet Med | 2021 |
| 33658631 | Disruption of RFX family transcription factors causes autism, attention-deficit/hyperactivity disorder, intellectual disability, and dysregulated behavior. | Genet Med | 2021 |
| 34519438 | Novel variants in KAT6B spectrum of disorders expand our knowledge of clinical manifestations and molecular mechanisms. | Mol Genet Genomic Med | 2021 |
| 33658631 | Disruption of RFX family transcription factors causes autism, attention-deficit/hyperactivity disorder, intellectual disability, and dysregulated behavior. | Genet Med | 2021 |
| 34519438 | Novel variants in KAT6B spectrum of disorders expand our knowledge of clinical manifestations and molecular mechanisms. | Mol Genet Genomic Med | 2021 |
| 32820185 | Homozygous deletions implicate non-coding epigenetic marks in Autism spectrum disorder. | Sci Rep | 2020 |
| 32022391 | A phenotypically severe, biochemically "silent" case of HIBCH deficiency in a newborn diagnosed by rapid whole exome sequencing and enzymatic testing. | Am J Med Genet A | 2020 |
| 31780822 | Prospective, phenotype-driven selection of critically ill neonates for rapid exome sequencing is associated with high diagnostic yield. | Genet Med | 2020 |
| 32655885 | Children's rare disease cohorts: an integrative research and clinical genomics initiative. | NPJ Genom Med | 2020 |
| 32820185 | Homozygous deletions implicate non-coding epigenetic marks in Autism spectrum disorder. | Sci Rep | 2020 |
| 31780822 | Prospective, phenotype-driven selection of critically ill neonates for rapid exome sequencing is associated with high diagnostic yield. | Genet Med | 2020 |
| 32022391 | A phenotypically severe, biochemically "silent" case of HIBCH deficiency in a newborn diagnosed by rapid whole exome sequencing and enzymatic testing. | Am J Med Genet A | 2020 |
| 32655885 | Children's rare disease cohorts: an integrative research and clinical genomics initiative. | NPJ Genom Med | 2020 |
| 30609409 | Interpretation of Genomic Sequencing Results in Healthy and Ill Newborns: Results from the BabySeq Project. | Am J Hum Genet | 2019 |
| 30209271 | Parental interest in genomic sequencing of newborns: enrollment experience from the BabySeq Project. | Genet Med | 2019 |
| 30609409 | Interpretation of Genomic Sequencing Results in Healthy and Ill Newborns: Results from the BabySeq Project. | Am J Hum Genet | 2019 |
| 30979967 | Unique bioinformatic approach and comprehensive reanalysis improve diagnostic yield of clinical exomes. | Eur J Hum Genet | 2019 |
| 31209396 | Recessive gene disruptions in autism spectrum disorder. | Nat Genet | 2019 |
| 31395954 | Infant mortality: the contribution of genetic disorders. | J Perinatol | 2019 |
| 30209271 | Parental interest in genomic sequencing of newborns: enrollment experience from the BabySeq Project. | Genet Med | 2019 |
| 31209396 | Recessive gene disruptions in autism spectrum disorder. | Nat Genet | 2019 |
| 31395954 | Infant mortality: the contribution of genetic disorders. | J Perinatol | 2019 |
| 30979967 | Unique bioinformatic approach and comprehensive reanalysis improve diagnostic yield of clinical exomes. | Eur J Hum Genet | 2019 |
| 29068161 | DCC mutation update: Congenital mirror movements, isolated agenesis of the corpus callosum, and developmental split brain syndrome. | Hum Mutat | 2018 |
| 29986673 | The BabySeq project: implementing genomic sequencing in newborns. | BMC Pediatr | 2018 |
| 29068161 | DCC mutation update: Congenital mirror movements, isolated agenesis of the corpus callosum, and developmental split brain syndrome. | Hum Mutat | 2018 |
| 29728376 | Reconciling newborn screening and a novel splice variant in <i>BTD</i> associated with partial biotinidase deficiency: a BabySeq Project case report. | Cold Spring Harb Mol Case Stud | 2018 |